Navigation Links
The 3rd Annual Burrill Personalized Medicine Meeting November 12-13, 2007 in San Francisco
Date:9/13/2007

Leading thinkers and senior executives from companies and government

organizations will gather for 3rd Annual Personalized Medicine event

produced by Burrill Life Sciences Media Group

SAN FRANCISCO, Sept. 13 /PRNewswire/ -- In the foreseeable future a trip to the doctor's office will be a radically different experience to what it is today. Armed with our complete genetic profile information about predisposition to disease, the appropriate remedial therapies, even what foods to eat will be part of the doctor's advice. While we can see the future of health care, we are still a tantalizing long way away from embracing it. There are many scientific, legal, ethical, regulatory and policy challenges that have to be addressed before personalized medicine becomes a reality in 21st century medicine.

The 3rd Burrill Personalized Medicine Meeting (San Francisco, November 12-13, 2007), hosted by Burrill Life Sciences Media Group, a joint venture of Nielsen Business Media and Burrill & Company, provides a "window" into these new realities with detailed discussions and analysis on the whole spectrum of personalized medicine -- from prediction to prevention and how they will have a major impact on the delivery of health care.

Some of the leading thinkers and senior executives from companies and government organizations will be participating in this event. Sessions include:

-- Personalized Medicine in the Clinic

-- How Science and Technology is Accelerating the Pace of Biomarker

Development

-- Targeted Treatments vs. The "one size fits all" Blockbuster

-- Pharmacogenomics comes of Age

-- The increasing role of Diagnostics in Personalized Medicine

-- Patient-centric Medicine -- Personalized Medicine from the Patient's

Point of View

-- The Regulatory Environment: The FDA's Perspective

The Burrill Personalized Medicine Meeting has established itself as a "must attend" event that not only embraces the current state of personalized medicine but also the business, finance, regulatory and reimbursement issues that are linked with this rapidly evolving field. It provides a forum for education, discussion and networking with the leaders in this field.

About Burrill Life Sciences Media Group

The Burrill Life Sciences Media Group, a joint venture of Burrill & Company and Nielsen Business Media, produces worldwide life sciences conferences, and leading publications including an annual book on the "State of the Industry, the 21st Edition is Biotech 2007: Life Sciences-A Global Transformation; a series of bio-intelligence reports including the Personalized Medicine Report, and The Journal of Life Sciences, in association with the California Healthcare Institute.

For further information:

Website: http://www.personalizedmedicinemeeting.com


'/>"/>
SOURCE Burrill Life Sciences Media Group
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. NameProtect releases annual list of top trademarkers
2. Doyle says new contracts saving state more than $16 million annually
3. Department of Commerce offers up to $1 million annually to aid tech entrepreneurs
4. Annual Bioethics Forum to explore genetic testing
5. Annual Conference Honors Tech Grant Winners
6. Winner of Burrill competition courted by North Carolina investors
7. Technology and business merge at UW Burrill Competition
8. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
9. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
10. Students Win Burrill Competition With Plan for Renewable Energy
11. Romanian Student Leverages Burrill Competition to Accomplish Her Dream
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... Mass. , June 23, 2016   ... development of novel compounds designed to target cancer ... napabucasin, has been granted Orphan Drug Designation from ... the treatment of gastric cancer, including gastroesophageal junction ... stemness inhibitor designed to inhibit cancer stemness pathways ...
(Date:6/23/2016)... 23, 2016 A person commits a crime, and ... to track the criminal down. An outbreak of ... Drug Administration (FDA) uses DNA evidence to track down the ... Sound far-fetched? It,s not. The FDA has increasingly used a ... of foodborne illnesses. Put as simply as possible, whole genome ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... YM (Yeast and Mold) microbial test has received AOAC Research Institute approval 061601. ... microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory and ...
(Date:6/23/2016)... , June, 23, 2016  The Biodesign Challenge ... envision new ways to harness living systems and biotechnology, ... Art (MoMA) in New York City ... 130 participating students, showcased projects at MoMA,s Celeste Bartos ... Paola Antonelli , MoMA,s senior curator of architecture and ...
Breaking Biology Technology:
(Date:6/16/2016)... June 16, 2016 The ... expected to reach USD 1.83 billion by 2024, ... Research, Inc. Technological proliferation and increasing demand in ... expected to drive the market growth. ... The development of advanced multimodal techniques for ...
(Date:6/9/2016)... , June 9, 2016  Perkotek an innovation leader in attendance control systems ... seamlessly log work hours, for employers to make sure the right employees are actually ... http://photos.prnewswire.com/prnh/20160609/377486LOGO ... ... ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. ... a business relationship that includes integrating Syngrafii,s patented ... branch project. This collaboration will result in greater ... the credit union, while maintaining existing document workflow ... http://photos.prnewswire.com/prnh/20160606/375871LOGO ...
Breaking Biology News(10 mins):